VLP Therapeutics
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Intratumoral Delivery of Viral Replicon (saRNA) Particles Expressing IL-12 in Head and Neck Cancer (NCT06736379) | VLP Therapeutics | 2025-05-13 |
| To Assess the Safety, Immunogenicity and Efficacy of VLPM01 in Healthy, Malaria-Naïve Volunteers (NCT03867331) | VLP Therapeutics | 2019-03-13 |
Track VLP Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.